Amundi
LH icon

Amundi’s Labcorp LH Stock Holding History

Amundi’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$167M Buy
596,662
+322,478
+118% +$84.8M 0.04% 343
2026
Q1 		$73.2M Buy
274,184
+34,351
+14% +$9.3M 0.02% 513
2025
Q4 		$60.2M Sell
239,833
-4,685
-2% -$1.24M 0.02% 592
2025
Q3 		$67.3M Sell
244,518
-29,789
-11% -$7.98M 0.02% 493
2025
Q2 		$71.3M Sell
274,307
-799,075
-74% -$195M 0.02% 486
2025
Q1 		$251M Sell
1,073,382
-50,027
-4% -$12.1M 0.09% 222
2024
Q4 		$263M Buy
1,123,409
+870,903
+345% +$200M 0.09% 212
2024
Q3 		$53.7M Buy
252,506
+10,204
+4% +$2.24M 0.02% 532
2024
Q2 		$49.4M Buy
242,302
+45,373
+23% +$9.23M 0.02% 526
2024
Q1 		$39.3M Buy
196,929
+27,000
+16% +$5.95M 0.02% 572
2023
Q4 		$38.8M Sell
169,929
-19,693
-10% -$4.14M 0.02% 585
2023
Q3 		$38.2M Sell
189,622
-24,632
-11% -$5.2M 0.02% 562
2023
Q2 		$38.5M Sell
214,254
-120,535
-36% -$23.4M 0.02% 572
2023
Q1 		$67.3M Sell
334,789
-144,180
-30% -$29.7M 0.04% 437
2022
Q4 		$103M Sell
478,969
-31,609
-6% -$6.18M 0.06% 340
2022
Q3 		$93.6M Buy
510,578
+338,673
+197% +$69.3M 0.06% 351
2022
Q2 		$35.5M Buy
171,905
+22,816
+15% +$4.86M 0.03% 509
2022
Q1 		$34.8M Sell
149,089
-61,678
-29% -$14.5M 0.02% 540
2021
Q4 		$50.3M Sell
210,767
-35,913
-15% -$8.89M 0.03% 474
2021
Q3 		$59.6M Sell
246,680
-22,320
-8% -$5.63M 0.04% 412
2021
Q2 		$63.8M Buy
+269,000
New +$61.3M 0.04% 393

Other funds holding LH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Amundi's LH Position: Q2 2026 in Review

Amundi increased its Labcorp (LH) stake by 118% in Q2 2026, buying an estimated $84.8M and bringing the position to 596,662 shares worth $167M. The position accounts for 0.04% of the portfolio, ranked #343.

Amundi first reported a position in LH in Q2 2021 and has held it in 21 quarters since. The position peaked at $263M in Q4 2024. 1,056 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Amundi held 596,662 shares of Labcorp worth $167M as of Q2 2026.
  • Amundi bought 322,478 Labcorp shares in Q2 2026, an estimated $84.8M.
  • Labcorp made up 0.04% of Amundi's portfolio in Q2 2026, its #343 holding.
  • Amundi first reported a position in Labcorp in Q2 2021 and has held it in 21 quarters since.
  • Amundi's Labcorp position peaked at $263M in Q4 2024.
  • 1,056 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Amundi's 13F filing for Q2 2026, filed 11 Aug 2026.